메뉴 건너뛰기




Volumn 7, Issue 2, 2012, Pages 70-77

Treatment prospects of Helicobacter pylori infection;Perspektywy leczenia zakażenia Helicobacter pylori

Author keywords

Antibiotic treatment; Eradication; Helicobacter pylori infection

Indexed keywords

CLINICAL TRIAL (TOPIC); HELICOBACTER INFECTION; REVIEW; TREATMENT FAILURE;

EID: 84861742472     PISSN: 18955770     EISSN: 18974317     Source Type: Journal    
DOI: 10.5114/pg.2012.28647     Document Type: Review
Times cited : (3)

References (46)
  • 1
    • 0021259505 scopus 로고
    • Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
    • Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 323: 1311-5.
    • (1984) Lancet , vol.323 , pp. 1311-1315
    • Marshall, B.J.1    Warren, J.R.2
  • 3
    • 70350641941 scopus 로고    scopus 로고
    • Grupa Robocza PTG-E do spraw zakażenia Helicobacter pylori. Ustalenia Grupy Roboczej PTGE dotycza̧ce postȩpowania w zakażeniu Helicobacter pylori -consensus 2008
    • Dzieniszewski J, Jarosz M; Grupa Robocza PTG-E do spraw zakażenia Helicobacter pylori. Ustalenia Grupy Roboczej PTGE dotycza̧ce postȩpowania w zakażeniu Helicobacter pylori -consensus 2008. Gastroenterol Pol 2008; 15: 323-31.
    • (2008) Gastroenterol Pol , vol.15 , pp. 323-331
    • Dzieniszewski, J.1    Jarosz, M.2
  • 4
    • 73849138182 scopus 로고    scopus 로고
    • Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability
    • Luther J, Higgins PD, Schoenfeld PS, et al. Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: systematic review and meta-analysis of efficacy and tolerability. Am J Gastroenterol 2010; 105: 65-73.
    • (2010) Am J Gastroenterol , vol.105 , pp. 65-73
    • Luther, J.1    Higgins, P.D.2    Schoenfeld, P.S.3
  • 5
    • 0035123052 scopus 로고    scopus 로고
    • Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate
    • DOI 10.1046/j.1365-2036.2001.00931.x
    • Fakheri H, Malekzadeh R, Merat S, et al. Clarithromycin vs. furazolidone in quadruple therapy regiment for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate. Aliment Pharmacol Ther 2001; 15: 411-6. (Pubitemid 32192865)
    • (2001) Alimentary Pharmacology and Therapeutics , vol.15 , Issue.3 , pp. 411-416
    • Fakheri, H.1    Malekzadeh, R.2    Merat, S.3    Khatibian, M.4    Fazel, A.5    Alizadeh, B.Z.6    Massarrat, S.7
  • 6
    • 4344592305 scopus 로고    scopus 로고
    • H. pylori antibiotic resistance: Prevalence, importance and advances in testing
    • Megraud F. H. pylori antibiotic resistance: prevalence, importance and advances in testing. Gut 2004; 53: 1374-84.
    • (2004) Gut , vol.53 , pp. 1374-1384
    • Megraud, F.1
  • 8
    • 35449004823 scopus 로고    scopus 로고
    • Correlation between substitutions in penicillin-binding protein 1 and amoxicillin resistance in Helicobacter pylori
    • Rimbara E, Noguchi N, Kawai T, Sasatsu M. Correlation between substitutions in penicillin binding protein 1 and amoxicillin resistance in Helicobacter pylori. Microbiol Inmunol 2007; 51: 939-44. (Pubitemid 47623407)
    • (2007) Microbiology and Immunology , vol.51 , Issue.10 , pp. 939-944
    • Rimbara, E.1    Noguchi, N.2    Kawai, T.3    Sasatsu, M.4
  • 9
    • 64649086513 scopus 로고    scopus 로고
    • Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard therapy: A randomized controlled trail
    • Kuo CH, Hu HM, Kuo FC, et al. Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard therapy: a randomized controlled trail. J Antimicrob Chemother 2009; 63: 1017-24.
    • (2009) J Antimicrob Chemother , vol.63 , pp. 1017-1024
    • Kuo, C.H.1    Hu, H.M.2    Kuo, F.C.3
  • 10
    • 37849047500 scopus 로고    scopus 로고
    • Second line rescue therapy with levofloxacin after H. pylori treatment failure: A Spanish multicenter study of 300 Patients
    • Gisbert JP, Bermejo F, Castro-Fernandez M, et al. Second line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 Patients. Am J Gastroenterol 2008; 103: 71-6.
    • (2008) Am J Gastroenterol , vol.103 , pp. 71-76
    • Gisbert, J.P.1    Bermejo, F.2    Castro-Fernandez, M.3
  • 11
    • 67349145247 scopus 로고    scopus 로고
    • Second-line levofloxacin- based triple schemes for Helicobacter pylori eradication
    • di Caro S, Franceschi F, Mariani A, et al. Second-line levofloxacin- based triple schemes for Helicobacter pylori eradication. Dig Liver Dis 2009; 41: 480-5.
    • (2009) Dig Liver Dis , vol.41 , pp. 480-485
    • Di Caro, S.1    Franceschi, F.2    Mariani, A.3
  • 12
    • 33644925601 scopus 로고    scopus 로고
    • Systematic review and meta-analysis: Levofloxacin-based rescue regimens after Helicobacter pylori treatment failure
    • DOI 10.1111/j.1365-2036.2006.02737.x
    • Gisbert JP, Morena F. Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Aliment Pharmacol Ther 2006; 23: 35-44. (Pubitemid 43381164)
    • (2006) Alimentary Pharmacology and Therapeutics , vol.23 , Issue.1 , pp. 35-44
    • Gisbert, J.P.1    De La, M.F.2
  • 13
    • 77950841072 scopus 로고    scopus 로고
    • Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days moxifloxacin based therapy for the eradication: A randomized controlled trial
    • Bago J, Majstorović K, Belošić-Halle Z, et al. Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days moxifloxacin based therapy for the eradication: a randomized controlled trial. Ann Clin Microbiol Antimicrob 2010; 9: 13.
    • (2010) Ann Clin Microbiol Antimicrob , vol.9 , pp. 13
    • Bago, J.1    Majstorović, K.2    Belošić-Halle, Z.3
  • 14
    • 73749088673 scopus 로고    scopus 로고
    • Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment
    • Sacco F, Spezzaferro M, Amitrano M, et al. Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment. Dig Liver Dis 2010; 42: 110-4.
    • (2010) Dig Liver Dis , vol.42 , pp. 110-114
    • Sacco, F.1    Spezzaferro, M.2    Amitrano, M.3
  • 15
    • 38149058786 scopus 로고    scopus 로고
    • One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin
    • Miehlke S, Schneider-Brachert W, Kirsch C, et al. One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin. Helicobacter 2008; 13: 69-74.
    • (2008) Helicobacter , vol.13 , pp. 69-74
    • Miehlke, S.1    Schneider-Brachert, W.2    Kirsch, C.3
  • 16
    • 33745877144 scopus 로고    scopus 로고
    • Efficacy and safety of rabeprazole, amoxicillin, and gatifloxacin after treatment failure of initial Helicobacter pylori eradication
    • DOI 10.1111/j.1523-5378.2006.00416.x
    • Sharara AI, Chaar HF, Aoun E, et al. Efficacy and safety of rabeprazole, amoxicillin, and gatifloxacin after treatment failure of initial Helicobacter pylori eradication. Helicobacter 2006; 11: 231-6. (Pubitemid 44051348)
    • (2006) Helicobacter , vol.11 , Issue.4 , pp. 231-236
    • Sharara, A.I.1    Chaar, H.F.2    Aoun, E.3    Abdul-Baki, H.4    Araj, G.F.5    Kanj, S.S.6
  • 17
    • 57449094600 scopus 로고    scopus 로고
    • Gatifloxacin-based triple therapy as third-line regimen for Helicobacter pylori eradication
    • Nishizawa T, Suzuki H, Nakagawa I, et al. Gatifloxacin-based triple therapy as third-line regimen for Helicobacter pylori eradication. J Gastroenterol Hepatol 2008; 23: 167-70.
    • (2008) J Gastroenterol Hepatol , vol.23 , pp. 167-170
    • Nishizawa, T.1    Suzuki, H.2    Nakagawa, I.3
  • 18
    • 84861723085 scopus 로고    scopus 로고
    • Comparison of triple rabeprazole/metronidazol/sitafloxacin therapy with triple rabeprazole/ amoxicillin/sitafloxacin therapy as the third rescue regimen for eradication of H. pylori
    • Furuta T, Sugimoto M, Codaira C, et al. Comparison of triple rabeprazole/metronidazol/sitafloxacin therapy with triple rabeprazole/ amoxicillin/sitafloxacin therapy as the third rescue regimen for eradication of H. pylori. Helicobacter 2010; 14: 28.
    • (2010) Helicobacter , vol.14 , pp. 28
    • Furuta, T.1    Sugimoto, M.2    Codaira, C.3
  • 20
    • 36549063070 scopus 로고    scopus 로고
    • The effectiveness of rifabutin triple therapy for patients with difficult-to-eradicate Helicobacter pylori in clinical practice
    • DOI 10.1111/j.1365-2036.2007.03531.x
    • van der Poorten D, Katelaris PH. The effectiveness of rifabutin triple therapy for patients with difficult-to-eradicate Helicobacter pylori in clinical practice. Aliment Pharmacol Ther 2007; 26: 1537-42. (Pubitemid 350178803)
    • (2007) Alimentary Pharmacology and Therapeutics , vol.26 , Issue.11-12 , pp. 1537-1542
    • Van Der, P.D.1    Katelaris, P.H.2
  • 21
    • 2142751121 scopus 로고    scopus 로고
    • Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts
    • DOI 10.1016/S1590-8658(03)00268-8, PII S1590865803002688
    • Parente F, Cucino C, Bianchi-Porro G, et al. Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts. Dig Liver Dis 2003; 35: 523-8. (Pubitemid 41070406)
    • (2003) Digestive and Liver Disease , vol.35 , Issue.8 , pp. 523-528
    • Parente, F.1    Cucino, C.2    Bianchi, P.G.3
  • 22
    • 33750435590 scopus 로고    scopus 로고
    • Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures
    • DOI 10.1111/j.1365-2036.2006.03149.x
    • Gisbert JP, Gisbert JL, Marcos S, et al. Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures. Aliment Pharmacol Ther 2006; 24: 1469-74. (Pubitemid 44657124)
    • (2006) Alimentary Pharmacology and Therapeutics , vol.24 , Issue.10 , pp. 1469-1474
    • Gisbert, J.P.1    Gisbert, J.L.2    Marcos, S.3    Moreno-Otero, R.4    Pajares, J.M.5
  • 23
    • 38149041576 scopus 로고    scopus 로고
    • Empirical rescue therapy after Helicobacter pylori treatment failure: A 10-year single-centre study of 500 patients
    • Gisbert JP, Gisbert JL, Marcos S, et al. Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients. Aliment Pharmacol Ther 2008; 27: 346-54.
    • (2008) Aliment Pharmacol Ther , vol.27 , pp. 346-354
    • Gisbert, J.P.1    Gisbert, J.L.2    Marcos, S.3
  • 25
    • 0035123052 scopus 로고    scopus 로고
    • Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate
    • DOI 10.1046/j.1365-2036.2001.00931.x
    • Fakheri H, Malekzadeh R, Merat S. Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate. Aliment Pharmacol Ther 2001; 15: 411-6. (Pubitemid 32192865)
    • (2001) Alimentary Pharmacology and Therapeutics , vol.15 , Issue.3 , pp. 411-416
    • Fakheri, H.1    Malekzadeh, R.2    Merat, S.3    Khatibian, M.4    Fazel, A.5    Alizadeh, B.Z.6    Massarrat, S.7
  • 27
    • 34948911342 scopus 로고    scopus 로고
    • The sequential therapy regimen for Helicobacter pylori eradication: A pooled-data analysis
    • DOI 10.1136/gut.2007.125658
    • Zullo A, de Francesco V, Hassan C, et al. The sequential therapy regimen for Helicobacter pylori eradication. Gut 2007; 56: 1353-7. (Pubitemid 47517826)
    • (2007) Gut , vol.56 , Issue.10 , pp. 1353-1357
    • Zullo, A.1    De Francesco, V.2    Hassan, C.3    Morini, S.4    Vaira, D.5
  • 28
    • 0036161402 scopus 로고    scopus 로고
    • Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy
    • DOI 10.1016/S0924-8579(01)00456-3, PII S0924857901004563
    • Murakami K, Fujioka T, Okimoto T, et al. Drug combinations with amoxicillin reduces selection of clarithromycin resistance during Helicobacter pylori eradication therapy. Int J Antimicrob Agents 2002; 19: 67-70. (Pubitemid 34119073)
    • (2002) International Journal of Antimicrobial Agents , vol.19 , Issue.1 , pp. 67-70
    • Murakami, K.1    Fujioka, T.2    Okimoto, T.3    Sato, R.4    Kodama, M.5    Nasu, M.6
  • 29
    • 77949933512 scopus 로고    scopus 로고
    • Ten and eight-day sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection: A randomized controlled study on efficacy and tolerability
    • Paoluzi OA, Visconti E, Andrei F, et al. Ten and eight-day sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection: a randomized controlled study on efficacy and tolerability. J Clin Gastroenterol 2010; 44: 261-6.
    • (2010) J Clin Gastroenterol , vol.44 , pp. 261-266
    • Paoluzi, O.A.1    Visconti, E.2    Andrei, F.3
  • 30
    • 72949096113 scopus 로고    scopus 로고
    • Sequential therapy or triple therapy for Helicobacter pylori infection: Systemic review and meta-analysis of randomized controlled trials in adults and children
    • Gatta L, Vakil N, Leandro G, et al. Sequential therapy or triple therapy for Helicobacter pylori infection: systemic review and meta-analysis of randomized controlled trials in adults and children. Am J Gastroenterol 2009; 104: 3069-79.
    • (2009) Am J Gastroenterol , vol.104 , pp. 3069-3079
    • Gatta, L.1    Vakil, N.2    Leandro, G.3
  • 31
    • 78049503288 scopus 로고    scopus 로고
    • Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: A randomised trial
    • Romano M, Cuomo A, Gravina AG, et al. Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial. Gut 2010; 59: 1465-70.
    • (2010) Gut , vol.59 , pp. 1465-1470
    • Romano, M.1    Cuomo, A.2    Gravina, A.G.3
  • 32
    • 77949885213 scopus 로고    scopus 로고
    • Sequential therapy for Helicobacter pylori eradication: The time is now!
    • Vaira D, Zullo A, Hassan C, et al. Sequential therapy for Helicobacter pylori eradication: the time is now! Therap Adv Gastroenterol 2009; 2: 317-22.
    • (2009) Therap Adv Gastroenterol , vol.2 , pp. 317-322
    • Vaira, D.1    Zullo, A.2    Hassan, C.3
  • 33
    • 27744501086 scopus 로고    scopus 로고
    • Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: A randomized trial
    • Francavilla R, Lionetti E, Castellaneta SP, et al. Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. Gastroenterology 2005; 129: 1414-5.
    • (2005) Gastroenterology , vol.129 , pp. 1414-1415
    • Francavilla, R.1    Lionetti, E.2    Castellaneta, S.P.3
  • 34
    • 33644798246 scopus 로고    scopus 로고
    • Clarithromycin-resistant genotypes and eradication of Helicobacter pylori
    • de Francesco V, Margiotta M, Zullo A, et al. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. Ann Intern Med 2006; 144: 94-100.
    • (2006) Ann Intern Med , vol.144 , pp. 94-100
    • De Francesco, V.1    Margiotta, M.2    Zullo, A.3
  • 35
    • 3543058738 scopus 로고    scopus 로고
    • Towards the ideal regimen for Helicobacter pylori eradication: The search continues
    • DOI 10.1016/j.dld.2004.01.004
    • Scarpignato C. Towards the ideal regimen for Helicobacter pylori eradication: the search continues. Dig Liver Dis 2004; 36: 243-7. (Pubitemid 41115471)
    • (2004) Digestive and Liver Disease , vol.36 , Issue.4 , pp. 243-247
    • Scarpignato, C.1
  • 36
    • 64549123418 scopus 로고    scopus 로고
    • Kliniczne znaczenie polimorfizmu wybranych genów cytochromu P-450 rodziny CYP1, podrodziny CYP2A, CYP2B oraz CYP2C
    • Wojtczak A, Skrȩtkowicz J. Kliniczne znaczenie polimorfizmu wybranych genów cytochromu P-450 rodziny CYP1, podrodziny CYP2A, CYP2B oraz CYP2C. Pol Merk Lek 2009; 153: 248-52.
    • (2009) Pol Merk Lek , vol.153 , pp. 248-252
    • Wojtczak, A.1    Skrȩtkowicz, J.2
  • 40
    • 79952280839 scopus 로고    scopus 로고
    • Citric acid inhibits growth of Helicobacter pylori in vitro: A new strategy for eradication
    • Zazgornik J, Mittermayer H. Citric acid inhibits growth of Helicobacter pylori in vitro: a new strategy for eradication. Wien Klin Wochenschr 2011; 123: 38-40.
    • (2011) Wien Klin Wochenschr , vol.123 , pp. 38-40
    • Zazgornik, J.1    Mittermayer, H.2
  • 41
    • 47949097028 scopus 로고    scopus 로고
    • Synthesis and in vitro anti-Helicobacter pylori activity of N-[5-(5-nitro-2-heteroaryl)-1,3,4-thiadiazol-2-yl]thiomorpholines and related compounds
    • Javad M, Siavoshi F, Emami S, et al. Synthesis and in vitro anti-Helicobacter pylori activity of N-[5-(5-nitro-2-heteroaryl)-1,3,4- thiadiazol-2-yl]thiomorpholines and related compounds. Eur J Med Chem 2008; 43: 1575-80.
    • (2008) Eur J Med Chem , vol.43 , pp. 1575-1580
    • Javad, M.1    Siavoshi, F.2    Emami, S.3
  • 44
    • 77955425222 scopus 로고    scopus 로고
    • Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides
    • Chimenti F, Bizzarri B, Bolasco A, et al. Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides. Bioorg Med Chem Lett 2010; 20: 4922-6.
    • (2010) Bioorg Med Chem Lett , vol.20 , pp. 4922-4926
    • Chimenti, F.1    Bizzarri, B.2    Bolasco, A.3
  • 45
    • 78650972161 scopus 로고    scopus 로고
    • Floating-bioadhesive microspheres of clarithromycin versus antibacterial agent caragenin CsA-13 for eradication of Helicobacter pylori resistant: Meta-analysis
    • Vaiciunas S, Oliveira MA, Bezerra IL, et al. Floating-bioadhesive microspheres of clarithromycin versus antibacterial agent caragenin CsA-13 for eradication of Helicobacter pylori resistant: meta-analysis. Gastroenterology 2010; 138: 339-40.
    • (2010) Gastroenterology , vol.138 , pp. 339-340
    • Vaiciunas, S.1    Oliveira, M.A.2    Bezerra, I.L.3
  • 46
    • 70349630154 scopus 로고    scopus 로고
    • Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juice
    • Leszczyńska K, Namiot A, Fein DE, et al. Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juice. BMC Microbiol 2009; 9: 187-9.
    • (2009) BMC Microbiol , vol.9 , pp. 187-189
    • Leszczyńska, K.1    Namiot, A.2    Fein, D.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.